(Q24241785)

30 June 2019

meta-analysis

0 references

review article

1 reference

title

Artemisinin-based combination therapy for treating uncomplicated malaria (English)

1 reference

30 June 2019

0 references

0 references

2

0 references

Sarah Donegan

3

0 references

Paul Garner

5

0 references

Piero Olliaro

4

object named as

Piero Olliaro

1 reference

30 June 2019

David Sinclair

1

object named as

David Sinclair

1 reference

30 June 2019

publication date

8 July 2009

1 reference

30 June 2019

Cochrane Database of Systematic Reviews

published in

1 reference

30 June 2019

issue

3

1 reference

30 June 2019

page(s)

CD007483

1 reference

30 June 2019

Randomized, controlled dose-optimization studies of dihydroartemisinin-piperaquine for the treatment of uncomplicated multidrug-resistant falciparum malaria in Thailand

cites work

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007483.PUB2

An open label randomized comparison of mefloquine-artesunate as separate tablets vs. a new co-formulated combination for the treatment of uncomplicated multidrug-resistant falciparum malaria in Thailand

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007483.PUB2

Efficacy of antimalarial treatment in Guinea: in vivo study of two artemisinin combination therapies in Dabola and molecular markers of resistance to sulphadoxine-pyrimethamine in N'Zérékoré

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007483.PUB2

Combination therapy for uncomplicated falciparum malaria in Ugandan children: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007483.PUB2

High efficacy of two artemisinin-based combinations (artemether-lumefantrine and artesunate plus amodiaquine) for acute uncomplicated malaria in Ibadan, Nigeria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007483.PUB2

Antimalarial efficacy of chloroquine, amodiaquine, sulfadoxine-pyrimethamine, and the combinations of amodiaquine + artesunate and sulfadoxine-pyrimethamine + artesunate in Huambo and Bie provinces, central Angola

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007483.PUB2

Malaria in the Nuba Mountains of Sudan: baseline genotypic resistance and efficacy of the artesunate plus sulfadoxine-pyrimethamine and artesunate plus amodiaquine combinations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007483.PUB2

Dihydroartemisinin-piperaquine versus artesunate-amodiaquine: superior efficacy and posttreatment prophylaxis against multidrug-resistant Plasmodium falciparum and Plasmodium vivax malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007483.PUB2

Artemether-lumefantrine versus dihydroartemisinin-piperaquine for treatment of malaria: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007483.PUB2

Safety and efficacy of dihydroartemisinin/piperaquine (Artekin) for the treatment of uncomplicated Plasmodium falciparum malaria in Rwandan children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007483.PUB2

A trial of combination antimalarial therapies in children from Papua New Guinea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007483.PUB2

Artemisinin-based combinations versus amodiaquine plus sulphadoxine-pyrimethamine for the treatment of uncomplicated malaria in Faladje, Mali

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007483.PUB2

A randomized trial on effectiveness of artemether-lumefantrine versus artesunate plus amodiaquine for unsupervised treatment of uncomplicated Plasmodium falciparum malaria in Ghanaian children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007483.PUB2

Efficacy of artesunate plus amodiaquine versus that of artemether-lumefantrine for the treatment of uncomplicated childhood Plasmodium falciparum malaria in Zanzibar, Tanzania

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007483.PUB2

An open, randomized comparison of artesunate plus mefloquine vs. dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in the Lao People's Democratic Republic (Laos).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007483.PUB2

A comparative study on the efficacy of artesunate plus sulphadoxine/pyrimethamine versus artemether-lumefantrine in eastern Sudan

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007483.PUB2

Amodiaquine alone, amodiaquine+sulfadoxine-pyrimethamine, amodiaquine+artesunate, and artemether-lumefantrine for outpatient treatment of malaria in Tanzanian children: a four-arm randomised effectiveness trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007483.PUB2

An open label, randomised trial of artesunate+amodiaquine, artesunate+chlorproguanil-dapsone and artemether-lumefantrine for the treatment of uncomplicated malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007483.PUB2

Two fixed-dose artemisinin combinations for drug-resistant falciparum and vivax malaria in Papua, Indonesia: an open-label randomised comparison

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007483.PUB2

Efficacy and effectiveness of dihydroartemisinin-piperaquine versus artesunate-mefloquine in falciparum malaria: an open-label randomised comparison.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007483.PUB2

Therapeutic efficacy of artemether-lumefantrine and artesunate-mefloquine for treatment of uncomplicated Plasmodium falciparum malaria in Luang Namtha Province, Lao People's Democratic Republic

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007483.PUB2

Artemether-lumefantrine for the treatment of multidrug-resistant falciparum malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007483.PUB2

Artemether-lumefantrine versus dihydroartemisinin-piperaquine for treating uncomplicated malaria: a randomized trial to guide policy in Uganda

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007483.PUB2

Artemether-lumefantrine versus amodiaquine plus sulfadoxine-pyrimethamine for uncomplicated falciparum malaria in Burkina Faso: a randomised non-inferiority trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007483.PUB2

Efficacy of chloroquine, amodiaquine, sulphadoxine-pyrimethamine and combination therapy with artesunate in Mozambican children with non-complicated malaria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007483.PUB2

Sulfadoxine-pyrimethamine-based combinations for malaria: a randomised blinded trial to compare efficacy, safety and selection of resistance in Malawi

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007483.PUB2

Therapeutic efficacy test in malaria falciparum in Antioquia, Colombia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007483.PUB2

Sulfadoxine/pyrimethamine alone or with amodiaquine or artesunate for treatment of uncomplicated malaria: a longitudinal randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007483.PUB2

Prevention of Increasing Rates of Treatment Failure by Combining Sulfadoxine‐Pyrimethamine with Artesunate or Amodiaquine for the Sequential Treatment of Malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007483.PUB2

Efficacy and safety of artemisinin-based antimalarial in the treatment of uncomplicated malaria in children in southern Tanzania

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007483.PUB2

Artemether-lumefantrine versus artesunate plus amodiaquine for treating uncomplicated childhood malaria in Nigeria: randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007483.PUB2

Safety and efficacy of lumefantrine-artemether (Coartem) for the treatment of uncomplicated Plasmodium falciparum malaria in Zambian adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007483.PUB2

Amodiaquine combined with sulfadoxine/pyrimethamine versus artemisinin-based combinations for the treatment of uncomplicated falciparum malaria in Africa: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007483.PUB2

Reduction of transmission from malaria patients by artemisinin combination therapies: a pooled analysis of six randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007483.PUB2

Supervised versus unsupervised intake of six-dose artemether-lumefantrine for treatment of acute, uncomplicated Plasmodium falciparum malaria in Mbarara, Uganda: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007483.PUB2

Open label randomized comparison of dihydroartemisinin-piperaquine and artesunate-amodiaquine for the treatment of uncomplicated Plasmodium falciparum malaria in central Vietnam

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007483.PUB2

Efficacy of two artemisinin combination therapies for uncomplicated falciparum malaria in children under 5 years, Malakal, Upper Nile, Sudan

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007483.PUB2

Artesunate combinations for treatment of malaria: meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007483.PUB2

Efficacy, safety and tolerability of artesunate-mefloquine in the treatment of uncomplicated Plasmodium falciparum malaria in four geographic zones of Nigeria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007483.PUB2

Sulfadoxine-pyrimethamine plus artesunate versus sulfadoxine-pyrimethamine plus amodiaquine for treating uncomplicated malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007483.PUB2

What is "quality of evidence" and why is it important to clinicians?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007483.PUB2

A randomized, double-blind study on the efficacy and safety of a practical three-day regimen with artesunate and mefloquine for the treatment of uncomplicated Plasmodium falciparum malaria in Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007483.PUB2

Mixed-species malaria infections in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007483.PUB2

Artemisinin derivatives for treating uncomplicated malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007483.PUB2

Comparison of oral artesunate and dihydroartemisinin antimalarial bioavailabilities in acute falciparum malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007483.PUB2

Artemether-lumefantrine (six-dose regimen) for treating uncomplicated falciparum malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007483.PUB2

Artemether-lumefantrine (four-dose regimen) for treating uncomplicated falciparum malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007483.PUB2

Effects of artemisinin derivatives on malaria transmissibility.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007483.PUB2

Therapeutic responses to different antimalarial drugs in vivax malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007483.PUB2

Artesunate reduces but does not prevent posttreatment transmission of Plasmodium falciparum to Anopheles gambiae.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007483.PUB2

Strategies for the prevention of antimalarial drug resistance: rationale for combination chemotherapy for malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007483.PUB2

Averting a malaria disaster

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007483.PUB2

The assessment of antimalarial drug efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007483.PUB2

Adverse effects in patients with acute falciparum malaria treated with artemisinin derivatives

21 January 2018

2 references

12 December 2020

https://api.crossref.org/works/10.1002%2F14651858.CD007483.PUB2

7 January 2021

inferred from DOI database lookup

Efficacy of six doses of artemether-lumefantrine (benflumetol) in multidrug-resistant Plasmodium falciparum malaria

1 reference

12 December 2020

A clinical and pharmacokinetic trial of six doses of artemether-lumefantrine for multidrug-resistant Plasmodium falciparum malaria in Thailand

1 reference

12 December 2020

Antimalaria studies on Qinghaosu

1 reference

12 December 2020

Distinguishing recrudescence from reinfection in a longitudinal antimalarial drug efficacy study: comparison of results based on genotyping of msp-1, msp-2, and glurp.

1 reference

12 December 2020

An open randomized clinical trial of Artecom vs artesunate-mefloquine in the treatment of acute uncomplicated falciparum malaria in Thailand

1 reference

12 December 2020

Efficacy of amodiaquine alone and combined with sulfadoxine-pyrimethamine and of sulfadoxine pyrimethamine combined with artesunate

1 reference

12 December 2020

Dihydroartemisinin-piperaquine against multidrug-resistant Plasmodium falciparum malaria in Vietnam: randomised clinical trial

1 reference

12 December 2020

Efficacy of therapeutic combinations with artemisinin derivatives in the treatment of non complicated malaria in Burundi

1 reference

12 December 2020

Randomized comparison of chloroquine plus sulfadoxine-pyrimethamine versus artesunate plus mefloquine versus artemether-lumefantrine in the treatment of uncomplicated falciparum malaria in the Lao People's Democratic Republic

1 reference

12 December 2020

Combination treatments for uncomplicated falciparum malaria in Kampala, Uganda: randomised clinical trial

1 reference

12 December 2020

A randomized, placebo-controlled, double-blind trial on sulfadoxine-pyrimethamine alone or combined with artesunate or amodiaquine in uncomplicated malaria

1 reference

12 December 2020

A randomized, controlled study of a simple, once-daily regimen of dihydroartemisinin-piperaquine for the treatment of uncomplicated, multidrug-resistant falciparum malaria

1 reference

12 December 2020

Artemisinin versus nonartemisinin combination therapy for uncomplicated malaria: randomized clinical trials from four sites in Uganda

1 reference

12 December 2020

Comparative efficacy of antimalarial drugs including ACTs in the treatment of uncomplicated malaria among children under 5 years in Ghana

1 reference

12 December 2020

Efficacy of chloroquine + sulfadoxine--pyrimethamine, mefloquine + artesunate and artemether + lumefantrine combination therapies to treat Plasmodium falciparum malaria in the Chittagong Hill Tracts, Bangladesh

1 reference

12 December 2020

A randomized trial of artemether-lumefantrine versus mefloquine-artesunate for the treatment of uncomplicated multi-drug resistant Plasmodium falciparum on the western border of Thailand

1 reference

12 December 2020

Artesunate plus mefloquine versus mefloquine for treating uncomplicated malaria

1 reference

12 December 2020

The efficacies of artesunate-sulfadoxine-pyrimethamine and artemether-lumefantrine in the treatment of uncomplicated, Plasmodium falciparum malaria, in an area of low transmission in central Sudan

1 reference

12 December 2020

An open randomized clinical trial of Artekin vs artesunate-mefloquine in the treatment of acute uncomplicated falciparum malaria.

1 reference

12 December 2020

Moderate effect of artemisinin-based combination therapy on transmission of Plasmodium falciparum

1 reference

12 December 2020

High efficacy of two artemisinin-based combinations (artesunate + amodiaquine and artemether + lumefantrine) in Caala, Central Angola.

1 reference

12 December 2020

Artemisinin combination therapies for treatment of uncomplicated malaria in Uganda

1 reference

12 December 2020

Artesunate + amodiaquine and artesunate + sulphadoxine-pyrimethamine for treatment of uncomplicated malaria in Democratic Republic of Congo: a clinical trial with determination of sulphadoxine and pyrimethamine-resistant haplotypes.

1 reference

12 December 2020

A randomised trial to assess the safety and efficacy of artemether-lumefantrine (Coartem) for the treatment of uncomplicated Plasmodium falciparum malaria in Rwanda

1 reference

12 December 2020

The effects of artemether-lumefantrine vs amodiaquine-sulfalene-pyrimethamine on the hepatomegaly associated with Plasmodium falciparum malaria in children.

1 reference

12 December 2020

Cost-effectiveness study of three antimalarial drug combinations in Tanzania

1 reference

12 December 2020

A randomized trial of artesunate-sulfamethoxypyrazine-pyrimethamine versus artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Mali.

1 reference

12 December 2020

Efficacy of three artemisinin combination therapies for the treatment of uncomplicated Plasmodium falciparum malaria in the Republic of Congo

1 reference

12 December 2020

Efficacy of artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in northwest Cambodia.

1 reference

12 December 2020

Efficacies of artesunate plus either sulfadoxine-pyrimethamine or amodiaquine, for the treatment of uncomplicated, Plasmodium falciparum malaria in eastern Sudan.

1 reference

12 December 2020

A randomized open study to assess the efficacy and tolerability of dihydroartemisinin-piperaquine for the treatment of uncomplicated falciparum malaria in Cambodia.

1 reference

12 December 2020

Randomized clinical trial of artemisinin versus non-artemisinin combination therapy for uncomplicated falciparum malaria in Madagascar

1 reference

12 December 2020

Efficacy of artesunate plus amodiaquine, artesunate plus sulfadoxine-pyrimethamine, and chloroquine plus sulfadoxine-pyrimethamine in patients with uncomplicated Plasmodium falciparum in the Comoros Union

1 reference

12 December 2020

Efficacy and tolerability of four antimalarial combinations in the treatment of uncomplicated Plasmodium falciparum malaria in Senegal

1 reference

12 December 2020

Therapeutic efficacy and effects of artemether-lumefantrine and amodiaquine-sulfalene-pyrimethamine on gametocyte carriage in children with uncomplicated Plasmodium falciparum malaria in southwestern Nigeria.

1 reference

12 December 2020

Comparison of artemether-lumefantrine with sulfadoxine-pyrimethamine for the treatment of uncomplicated falciparum malaria in eastern Nepal.

1 reference

12 December 2020

A randomised controlled trial to assess the efficacy of dihydroartemisinin-piperaquine for the treatment of uncomplicated falciparum malaria in Peru

1 reference

12 December 2020

Randomized comparison of amodiaquine plus sulfadoxine-pyrimethamine, artemether-lumefantrine, and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Burkina Faso

1 reference

12 December 2020

Artemisinin-based combination treatment of falciparum malaria.

1 reference

12 December 2020

Efficacy, safety, and selection of molecular markers of drug resistance by two ACTs in Mali

1 reference

12 December 2020

Amodiaquine-artesunate vs artemether-lumefantrine for uncomplicated malaria in Ghanaian children: a randomized efficacy and safety trial with one year follow-up

1 reference

12 December 2020

A randomized trial of artesunate-mefloquine versus artemether-lumefantrine for treatment of uncomplicated Plasmodium falciparum malaria in Mali.

1 reference

12 December 2020

A randomized trial to monitor the efficacy and effectiveness by QT-NASBA of artemether-lumefantrine versus dihydroartemisinin-piperaquine for treatment and transmission control of uncomplicated Plasmodium falciparum malaria in western Kenya

1 reference

12 December 2020

Mefloquine therapy for Plasmodium falciparum malaria in children under 5 years of age in Malawi: in vivo/in vitro efficacy and correlation of drug concentration with parasitological outcome

1 reference

12 December 2020

Artemisinin and the antimalarial endoperoxides: from herbal remedy to targeted chemotherapy.

1 reference

12 December 2020

Randomized comparison of artemether-benflumetol and artesunate-mefloquine in treatment of multidrug-resistant falciparum malaria.

1 reference

12 December 2020

10.1002/14651858.CD007483.PUB2

Identifiers

DOI

1 reference

30 June 2019

OpenCitations bibliographic resource ID

568292

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

1 reference

30 June 2019

PubMed ID

19588433

1 reference

30 June 2019